Results 251 to 260 of about 79,837 (298)

Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
Zunino C   +7 more
europepmc   +1 more source

Supplementary Figure S1 from Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates

open access: gold
Mark E. Petersen   +20 more
openalex   +1 more source

Membrane Vesicles from Lacticaseibacillus Casei BL23 Exhibit Antimicrobial Activity Against Escherichia coli and Immunostimulatory Effects on Human Peripheral Blood Mononuclear Cells

open access: yesAdvanced Healthcare Materials, EarlyView.
Membrane vesicles derived from the probiotic Lacticaseibacillus casei BL23 demonstrate antimicrobial properties against Escherichia coli and a potential biological effect in improving the overall survival of C. elegans infected with Pseudomonas aeruginosa. These vesicles stimulated immune responses in primary cells without causing toxicity. Our results
Cecilia L. D'Antoni   +11 more
wiley   +1 more source

Supplementary Table 3 from Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody–Drug Conjugate TAK-500

open access: gold
Vicky A. Appleman   +27 more
openalex   +1 more source

Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC. [PDF]

open access: yesFront Oncol
Ramlau R   +9 more
europepmc   +1 more source

Supplementary Figure 12 from Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody–Drug Conjugate TAK-500

open access: gold
Vicky A. Appleman   +27 more
openalex   +1 more source

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models. [PDF]

open access: yesCell Rep Med
High PC   +7 more
europepmc   +1 more source

Supplementary Figure 5 from Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody–Drug Conjugate TAK-500

open access: gold
Vicky A. Appleman   +27 more
openalex   +1 more source

An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemia. [PDF]

open access: yesBlood Neoplasia
Gordon PM   +13 more
europepmc   +1 more source

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy. [PDF]

open access: yesWorld J Urol
Kessler C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy